Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALPS

ALPS Group Inc

Apr 30 • 02:28PM ET

0.9000

-0.0300 -3.23 %

Healthcare • Biotechnology • Malaysia • Micro • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.73	Insider Own	72.96%	Shs Outstand	166.40M	Perf Week	-1.64%
Market Cap	149.76M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	44.99M	Perf Month	-10.00%
Enterprise Value	155.31M	PEG	-	EPS next Q	-	Inst Own	0.38%	Short Float	0.08%	Perf Quarter	-3.22%
Income	-2.73M	P/S	-	EPS this Y	-	Inst Trans	156.47%	Short Ratio	1.17	Perf Half Y	-92.17%
Sales	0.00M	P/B	-	EPS next Y	-	ROA	-17.24%	Short Interest	0.04M	Perf YTD	3.52%
Book/sh	-3.19	P/C	415.99	EPS next 5Y	-	ROE	-62.50%	52W High	15.00 -94.00%	Perf Year	-91.91%
Cash/sh	0.00	P/FCF	-	EPS past 3/5Y	-175.18% -	ROIC	-	52W Low	0.56 60.09%	Perf 3Y	-91.38%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	2.44% 4.31%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-610.86%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	Feb 13, 2023	Quick Ratio	0.04	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.23	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.04	EPS Q/Q	-1113.92%	SMA20	-6.92%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-7.96%	Rel Volume	2.73	Prev Close	0.93
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	-81.81%	Avg Volume	30.72K	Price	0.90
IPO	Dec 23, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	65,116	Change	-3.23%

Apr-17-26 08:30AM	Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight (GlobeNewswire)
Feb-23-26 08:00AM	Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol (GlobeNewswire)
Jan-30-26 08:00AM	Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy (GlobeNewswire)
Jan-08-26 08:00AM	Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer (GlobeNewswire)
Oct-31-25 08:00AM	Alps Announces Closing of Business Combination with Globalink Investment Inc. (GlobeNewswire) -14.67%

Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company focuses on creating a fair healthcare ecosystem, to make advance predictive, preventive, and precision medicine accessible and affordable. The company is headquartered in Kuala Lumpur, Malaysia.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ALPS

ALPS Group Inc

Upgrade your Finviz experience